Case report: Pembrolizumab plus Axitinib related hypothyroid myopathy in two kidney cancer patients

被引:0
作者
Boutros, Andrea [1 ,2 ]
Vera, Lara [3 ]
Gatto, Federico [3 ]
Fornarini, Giuseppe [4 ]
Zanardi, Elisa [5 ]
机构
[1] IRCCS Osped Policlin San Martino, UO Oncol Med 2, Genoa, Italy
[2] Univ Genoa, Sch Med, Dept Internal Med & Med Special, Genoa, Italy
[3] IRCCS Policlin San Martino, Dept Internal Med, Endocrinol Unit, Genoa, Italy
[4] IRCCS Policlin San Martino, UO Oncol Med 1, Genoa, Italy
[5] IRCCS Osped Policlin San Martino, Dept Med Oncol, UO Clin Oncol Med, Genoa, Italy
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
pembrolizumab; axitinib; kidney cancer; hypothyroidism; myopathy; hypothyroid myopathy; immunotherapy; immune-relate adverse event; SUNITINIB;
D O I
10.3389/fonc.2022.1048526
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The first-line therapy in advanced kidney cancer has changed in recent years due to the introduction of combinations of tyrosine kinase inhibitors (TKIs) of vascular endothelial growth factor receptors (VEGFR) and immune checkpoint inhibitors (ICIs). Although immune-related adverse events are well-known, in the case of combination treatments, the determination of which drug is related to an adverse event may be challenging. We reported two cases of patients who developed muscle enzyme elevation in association with hypothyroidism during therapy with pembrolizumab plus axitinib for metastatic kidney cancer. The myopathy rapidly resolved after hormone replacement therapy with levothyroxine. Hypothyroid myopathy is a scarcely known and underreported adverse event. This adverse event may be relevant in the differential diagnosis with immune-related myositis, which has an autoimmune pathogenesis and a potentially fatal course.
引用
收藏
页数:5
相关论文
共 11 条
  • [1] Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma
    Choueiri, T. K.
    Powles, T.
    Burotto, M.
    Escudier, B.
    Bourlon, M. T.
    Zurawski, B.
    Juarez, V. M. Oyervides
    Hsieh, J. J.
    Basso, U.
    Shah, A. Y.
    Suarez, C.
    Hamzaj, A.
    Goh, J. C.
    Barrios, C.
    Richardet, M.
    Porta, C.
    Kowalyszyn, R.
    Feregrino, J. P.
    Zolnierek, J.
    Pook, D.
    Kessler, E. R.
    Tomita, Y.
    Mizuno, R.
    Bedke, J.
    Zhang, J.
    Maurer, M. A.
    Simsek, B.
    Ejzykowicz, F.
    Schwab, G. M.
    Apolo, A. B.
    Motzer, R. J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (09) : 829 - 841
  • [2] Fariduddin MM, 2022, Hypothyroid Myopathy
  • [3] Autoimmune Myasthenia, Primary Adrenal Insufficiency, and Progressive Hypothyroidism Due to Pembrolizumab and Axitinib Combination Regimen
    Figueroa-Perez, Nikole
    Kashyap, Rahul
    Bal, Deepinder
    Khan, Syed Anjum
    Pattan, Vishwanath
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
  • [4] Myalgias upon PD-1 checkpoint blockade: Think of immunotherapy induced hypothyroid myopathy
    He, Jian
    Xu, Jiang
    Gao, Jin
    Qian, Liting
    [J]. EUROPEAN JOURNAL OF CANCER, 2021, 155 : 38 - 41
  • [5] Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
    Motzer, Robert
    Alekseev, Boris
    Rha, Sun-Young
    Porta, Camillo
    Eto, Masatoshi
    Powles, Thomas
    Gruenwald, Viktor
    Hutson, Thomas E.
    Kopyltsov, Evgeny
    Mendez-Vidal, Maria J.
    Kozlov, Vadim
    Alyasova, Anna
    Hong, Sung-Hoo
    Kapoor, Anil
    Alonso Gordoa, Teresa
    Merchan, Jaime R.
    Winquist, Eric
    Maroto, Pablo
    Goh, Jeffrey C.
    Kim, Miso
    Gurney, Howard
    Patel, Vijay
    Peer, Avivit
    Procopio, Giuseppe
    Takagi, Toshio
    Melichar, Bohuslav
    Rolland, Frederic
    De Giorgi, Ugo
    Wong, Shirley
    Bedke, Jens
    Schmidinger, Manuela
    Dutcus, Corina E.
    Smith, Alan D.
    Dutta, Lea
    Mody, Kalgi
    Perini, Rodolfo F.
    Xing, Dongyuan
    Choueiri, Toni K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (14) : 1289 - 1300
  • [6] Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
    Motzer, Robert J.
    Penkov, Konstantin
    Haanen, John
    Rini, Brian
    Albiges, Laurence
    Campbell, Matthew T.
    Venugopal, Balaji
    Kollmannsberger, Christian
    Negrier, Sylvie
    Uemura, Motohide
    Lee, Jae L.
    Vasiliev, Aleksandr
    Miller, Wilson H., Jr.
    Gurney, Howard
    Schmidinger, Manuela
    Larkin, James
    Atkins, Michael B.
    Bedke, Jens
    Alekseev, Boris
    Wang, Jing
    Mariani, Mariangela
    Robbins, Paul B.
    Chudnovsky, Aleksander
    Fowst, Camilla
    Hariharan, Subramanian
    Huang, Bo
    di Pietro, Alessandra
    Choueiri, Toni K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (12) : 1103 - 1115
  • [7] Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial
    Powles, Thomas
    Plimack, Elizabeth R.
    Soulieres, Denis
    Waddell, Tom
    Stus, Viktor
    Gafanov, Rustem
    Nosov, Dmitry
    Pouliot, Frederic
    Melichar, Bohuslav
    Vynnychenko, Ihor
    Azevedo, Sergio J.
    Borchiellini, Delphine
    McDermott, Raymond S.
    Bedke, Jens
    Tamada, Satoshi
    Yin, Lina
    Chen, Mei
    Molife, L. Rhoda
    Atkins, Michael B.
    Rini, Brian, I
    [J]. LANCET ONCOLOGY, 2020, 21 (12) : 1563 - 1573
  • [8] Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline
    Rathmell, W. Kimryn
    Rumble, R. Bryan
    Van Veldhuizen, Peter J.
    Al-Ahmadie, Hikmat
    Emamekhoo, Hamid
    Hauke, Ralph J.
    Louie, Alexander, V
    Milowsky, Matthew, I
    Molina, Ana M.
    Rose, Tracy L.
    Siva, Shankar
    Zaorsky, Nicholas G.
    Zhang, Tian
    Qamar, Rubina
    Kungel, Terry M.
    Lewis, Bryan
    Singer, Eric A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (25) : 2957 - +
  • [9] RIGGS JE, 1990, MIL MED, V155, P171
  • [10] Immune Checkpoint Inhibitor-Associated Myositis A Distinct Form of Inflammatory Myopathy
    Saygin, Didem
    Ghosh, Nilasha
    Reid, Pankti
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (07) : 367 - 373